An investigation into Commure, and Medicare’s new-tech incentives for AI devices

An investigation into Commure, and Medicare's new-tech incentives for AI devices


Katie covers the impact of health technology on patients, clinicians, and businesses. Her stories explore the price tag of clinical AI, digital health at the FDA, and the boom in direct-to-consumer telehealth. Confidential tips can be sent on Signal at palmer.01.

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your inbox every Tuesday and Thursday.

Hello, health tech readers! Next week, the newsletter is going on its annual summer hiatus — we’ll see you back on the 25th.

Today, a deep dive into Commure, a company promising to automate the business of health care with artificial intelligence — and all the levers it’s pulling to make that happen. Let’s get right into it.

STAT+ Exclusive Story

STAT+

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.

Already have an account? Log in

View All Plans

To read the rest of this story subscribe to STAT+.

Subscribe



Source link

Leave a Reply